Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 8/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24966864 | 0.94 | GABRA1 (0.44) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966203 | 0.91 | BRD4 (0.42) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966832 | 0.89 | BRD4 (0.37) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24967341 | 0.87 | BRD4 (0.35) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24967340 | 0.86 | BRD4 (0.35) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966826 | 0.86 | BRD4 (0.39) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966983 | 0.83 | CYP1A2 (0.40) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966829 | 0.81 | GABRA1 (0.38) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966905 | 0.81 | CYP1A2 (0.40) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 | |
| SCHEMBL24966160 | 0.78 | GABRA1 (0.62) | CYP1A2CYP3A4GABRA1GABRB2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026724-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026724-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF | CYP21A2, CYP11B1, CYP11B2 | CYP1A2 42/4885CYP3A4 8/4885GABRA1 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.